from sdb ssr com scott ballantyn subject re burzynski antineoplaston in repli to jschwimmer wccnet wcc wesleyan edu messag apr est line organ scotsoft research in articl jschwimmer wccnet wcc wesleyan edu jschwimmer wccnet wcc wesleyan edu josh schwimmer write ani opinion burzynski antineoplaston inform current statu research would appreci burzynski work promis none antineoplaston shown antineoplast effect against experiment cancer the nci conduct test against leukemia mice result dose high enough produc toxic effect mice effect inhibit growth of tumor kill it these burzynski claim activ factor common and someth shown been extract he also shown actual distinct substanc the nci conduct seri test use against standard panel tumor includ differ cell line from tumor follow class leukemia non small cell and small cell lung cancer colon cancer cancer central nervou system melanoma ovarian cancer renal cancer exhibit neither growth inhibit cytotox dose level test it necessari process sinc solubl burzynski theori requir solubl agent basic hydrol to pag which call as pag inform carri peptid someth byrzynski claim necessari for antineoplast activ as also deriv mixtur pa pag pa also peptid purchas chemic suppli hous gram chemic extrem similar glutithamid thalidomid are habit form caus peripher neuropathi the nasti effect of thalidomid wide known in spite similar doe appear test potenti induc teratogen peripher neuropathi mani burzynski statement origin theori earli research past present support other work been shown untru sdb sdb ssr com